Atjaunināt sīkdatņu piekrišanu

Non-Hodgkin Lymphoma: Prognostic Factors and Targets 2013 ed. [Mīkstie vāki]

  • Formāts: Paperback / softback, 304 pages, height x width: 235x155 mm, weight: 4745 g, VI, 304 p., 1 Paperback / softback
  • Sērija : Cancer Drug Discovery and Development
  • Izdošanas datums: 25-Jun-2015
  • Izdevniecība: Springer-Verlag New York Inc.
  • ISBN-10: 148999419X
  • ISBN-13: 9781489994196
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 136,16 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Standarta cena: 160,19 €
  • Ietaupiet 15%
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Paperback / softback, 304 pages, height x width: 235x155 mm, weight: 4745 g, VI, 304 p., 1 Paperback / softback
  • Sērija : Cancer Drug Discovery and Development
  • Izdošanas datums: 25-Jun-2015
  • Izdevniecība: Springer-Verlag New York Inc.
  • ISBN-10: 148999419X
  • ISBN-13: 9781489994196
Citas grāmatas par šo tēmu:

The first publication to focus expressly on model organisms for lymphoma, the in-depth coverage provided by this volume has been edited by an acknowledged academic authority on the topic. The material details every factor informing judgments on prognosis.



This book will be the first that focuses on solely on model organisms for lymphoma. It's editors are internationally recognized in the field.
Cancer Stem Cells: A Matter of Perspective.- B and T-cell development.- HIV lymphomagenesis.- Epstein-Barr Virus Lymphomagenesis and Therapeutic Targets.- Antigen driven lymphomagenesis.- Pre-clinical lymphoma models.- Prognostic factors in B-cell lymphoma.- Prognostic factors in T-cell lymphoma.- Prognostic factors in HIV-associated lymphoma.- Future directions on the treatment of aggressive non-Hodgkin lymphoma.- New monoclonal antibodies for indolent non-Hodgkin lymphomas.- Current therapies for T-cell lymphoma.- Stem Cell Transplantation for lymphoma.- Autologous stem cell transplantation in non-Hodgkin lymphoma.- The role of Stem Cell Transplantation for HIV-associated lymphoma.- Stem Cell Transplantation for T-cell lymphoma.- Index.